1. Home
  2. AROW vs IVA Comparison

AROW vs IVA Comparison

Compare AROW & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • IVA
  • Stock Information
  • Founded
  • AROW 1851
  • IVA 2011
  • Country
  • AROW United States
  • IVA France
  • Employees
  • AROW N/A
  • IVA N/A
  • Industry
  • AROW Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • IVA Health Care
  • Exchange
  • AROW Nasdaq
  • IVA Nasdaq
  • Market Cap
  • AROW 436.8M
  • IVA 359.6M
  • IPO Year
  • AROW N/A
  • IVA 2020
  • Fundamental
  • Price
  • AROW $27.77
  • IVA $4.36
  • Analyst Decision
  • AROW Hold
  • IVA Strong Buy
  • Analyst Count
  • AROW 1
  • IVA 4
  • Target Price
  • AROW $28.00
  • IVA $10.50
  • AVG Volume (30 Days)
  • AROW 34.8K
  • IVA 26.8K
  • Earning Date
  • AROW 07-24-2025
  • IVA 09-24-2025
  • Dividend Yield
  • AROW 4.18%
  • IVA N/A
  • EPS Growth
  • AROW N/A
  • IVA N/A
  • EPS
  • AROW 1.83
  • IVA N/A
  • Revenue
  • AROW $140,422,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • AROW $22.74
  • IVA $44.22
  • Revenue Next Year
  • AROW $6.91
  • IVA $24.23
  • P/E Ratio
  • AROW $15.18
  • IVA N/A
  • Revenue Growth
  • AROW 5.15
  • IVA N/A
  • 52 Week Low
  • AROW $22.72
  • IVA $1.53
  • 52 Week High
  • AROW $34.63
  • IVA $4.36
  • Technical
  • Relative Strength Index (RSI)
  • AROW 54.78
  • IVA 74.37
  • Support Level
  • AROW $26.03
  • IVA $3.44
  • Resistance Level
  • AROW $29.21
  • IVA $3.58
  • Average True Range (ATR)
  • AROW 0.68
  • IVA 0.30
  • MACD
  • AROW 0.15
  • IVA 0.11
  • Stochastic Oscillator
  • AROW 57.27
  • IVA 100.00

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: